Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Prabhavathi Fernandes

Showing results (51-60 of 54) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 54 results.
Antimicrobial Agents and Chemotherapy|March 24, 2022
Reply to Kaye and Belley, "Third-Generation Cephalosporin-Resistant <i>Enterobacterales</i> Are Critical Priority Pathogens, Too!"Mark S Butler, Valeria Gigante, Hatim Sati, et al.
Antimicrobial Agents and Chemotherapy|July 15, 2024
Multi-year analysis of the global preclinical antibacterial pipeline: trends and gapsValeria Gigante, Richard A Alm, Daniela Melchiorri, et al.
Antimicrobial Agents and Chemotherapy|January 10, 2022
Analysis of the Clinical Pipeline of Treatments for Drug-Resistant Bacterial Infections: Despite Progress, More Action Is NeededMark S Butler, Valeria Gigante, Hatim Sati, et al.
The Lancet. Infectious Diseases|February 9, 2016
Efficacy and safety of oral solithromycin versus oral moxifloxacin for treatment of community-acquired bacterial pneumonia: a global, double-blind, multicentre, randomised, active-controlled, non-inferiority trial (SOLITAIRE-ORAL)Carlos M Barrera, Analia Mykietiuk, Hristo Metev, et al.
Pageof 6

Showing results (51-60 of 54) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 54 results.
Antimicrobial Agents and Chemotherapy|March 24, 2022
Reply to Kaye and Belley, "Third-Generation Cephalosporin-Resistant <i>Enterobacterales</i> Are Critical Priority Pathogens, Too!"Mark S Butler, Valeria Gigante, Hatim Sati, et al.
Antimicrobial Agents and Chemotherapy|July 15, 2024
Multi-year analysis of the global preclinical antibacterial pipeline: trends and gapsValeria Gigante, Richard A Alm, Daniela Melchiorri, et al.
Antimicrobial Agents and Chemotherapy|January 10, 2022
Analysis of the Clinical Pipeline of Treatments for Drug-Resistant Bacterial Infections: Despite Progress, More Action Is NeededMark S Butler, Valeria Gigante, Hatim Sati, et al.
The Lancet. Infectious Diseases|February 9, 2016
Efficacy and safety of oral solithromycin versus oral moxifloxacin for treatment of community-acquired bacterial pneumonia: a global, double-blind, multicentre, randomised, active-controlled, non-inferiority trial (SOLITAIRE-ORAL)Carlos M Barrera, Analia Mykietiuk, Hristo Metev, et al.
Pageof 6